New documents have investigators questioning inconsistencies and omissions in data reporting in the PLATO trial, building on ...
Tracer Biotechnologies, a next-generation diagnostics company, today announced a multi-year project with AstraZeneca (LSE/STO/Nasdaq: AZN). The agreement will enable AstraZeneca to use Tracer's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback